

Can't find Ashlyna 91 Day? Explore alternatives like Amethia, Camrese, and Jolessa — extended-cycle birth control options that work similarly.
You rely on Ashlyna 91 Day to prevent pregnancy and keep your periods to just four times a year. But when your pharmacy can't fill it — whether due to a stock-out, insurance issue, or supply chain problem — you need a backup plan. The good news? There are several alternatives that contain the same or very similar ingredients and work the same way.
In this post, we'll explain how Ashlyna works, then walk through the best alternatives your doctor can prescribe if Ashlyna isn't available.
Ashlyna 91 Day is an extended-cycle combination oral contraceptive made by Glenmark Generics. It's the generic version of the brand-name pill Seasonique.
Each pack contains 91 tablets:
You take one pill daily for 91 consecutive days. The result? You only get a period during the 7-day low-dose estrogen phase — about four times a year.
Ashlyna works through three mechanisms to prevent pregnancy:
The 7-day low-dose estrogen phase (instead of placebo pills) helps reduce breakthrough bleeding and provides a lighter, more predictable withdrawal bleed.
All of the following alternatives are extended-cycle oral contraceptives. Talk to your doctor before switching — they can help you choose the best option based on your health history and insurance coverage.
Amethia is another generic version of Seasonique with the exact same active ingredients and dosing schedule as Ashlyna:
If your pharmacy is out of Ashlyna, Amethia is the closest direct substitute. In most cases, your pharmacist can even make this swap without needing a new prescription from your doctor (though policies vary by state and pharmacy).
Price: Around $20–$50 with a discount card.
Camrese is a brand-name extended-cycle oral contraceptive that is essentially the same as Seasonique. It contains:
Because Camrese is a brand name, it may cost more without insurance. However, if your insurance specifically covers Camrese (or if a coupon brings the price down), it's an excellent alternative.
Price: $150–$350 without insurance; potentially $0 with insurance.
Jolessa is a generic of Seasonale (not Seasonique). The key difference is in the final 7 days:
Without the low-dose estrogen during the final week, you may experience slightly more breakthrough bleeding compared to Ashlyna. However, the contraceptive effectiveness is the same. Jolessa tends to be widely available and affordable.
Price: Around $15–$40 with a discount card.
Quasense is another generic of Seasonale, with the same formulation as Jolessa:
Like Jolessa, Quasense is a solid extended-cycle alternative. The only practical difference from Ashlyna is the lack of low-dose estrogen in the final week.
Price: Around $15–$45 with a discount card.
Switching between extended-cycle birth control pills is usually straightforward:
If none of the extended-cycle alternatives are available, your doctor might suggest switching to a standard 28-day birth control pill that contains similar hormones. You'd have a monthly period instead of a quarterly one, but you'd still have effective pregnancy prevention. Options include:
These use the same types of hormones but in a monthly cycle format.
Not being able to fill your Ashlyna prescription is frustrating, but you're not out of options. Amethia and Camrese are near-identical alternatives, while Jolessa and Quasense offer the same extended-cycle convenience with a slightly different final-week formulation.
Start by checking availability on Medfinder, then talk to your doctor about which alternative is right for you. Learn more about the current shortage situation or explore ways to save money on your prescription.
You focus on staying healthy. We'll handle the rest.
Try Medfinder Concierge FreeMedfinder's mission is to ensure every patient gets access to the medications they need. We believe this begins with trustworthy information. Our core values guide everything we do, including the standards that shape the accuracy, transparency, and quality of our content. We’re committed to delivering information that’s evidence-based, regularly updated, and easy to understand. For more details on our editorial process, see here.